1.
Efficacy of Secukinumab in Patients With Mild to Moderate Psoriasis: A Pooled Analysis of 6 Phase 3 Studies . J of Skin [Internet]. 2023 Nov. 13 [cited 2026 Apr. 29];7(6):s231. Available from: https://skin.dermsquared.com/skin/article/view/2453